Shanghai Shen Lian Biomedical Corp banner

Shanghai Shen Lian Biomedical Corp
SSE:688098

Watchlist Manager
Shanghai Shen Lian Biomedical Corp Logo
Shanghai Shen Lian Biomedical Corp
SSE:688098
Watchlist
Price: 7.94 CNY -6.26% Market Closed
Market Cap: ¥3.3B

Shanghai Shen Lian Biomedical Corp
Investor Relations

Shanghai Shen Lian Biomedical Corp. engages in the research, development, and manufacture of vaccines for the animal farming industry. The company is headquartered in Shanghai, Shanghai and currently employs 297 full-time employees. The company went IPO on 2019-10-28. The firm is committed to the research & development of foot and mouth disease vaccines, which are used to protect animals from foot and mouth diseases. The firm's main product are swine foot and mouth disease vaccines, and it also provides cattle foot and mouth disease vaccines, other swine vaccines, and other veterinary diagnostic reagents. The firm mainly sells its products within domestic market.

Show more
Loading
688098
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Dongsheng Nie
Chairman of the Board of Directors and Director of R&D Center
No Bio Available
Mr. Xu Gao
General Manager
No Bio Available
Mr. Bo Yin
Technical Director
No Bio Available
Ms. Haixia Yu
Board Secretary
No Bio Available
Mr. Zhen Zhang
Executive Deputy General Manager
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
No. 48, Jiangchuan East Road, Minhang District
Contacts
+862161257979
www.slbio.com.cn
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett